Clinical Research Directory
Browse clinical research sites, groups, and studies.
68Ga-ICAM-1pep PET/CT in Cancer Patients
Sponsor: Peking University Cancer Hospital & Institute
Summary
This is an open-label positron emission tomography/computed tomography (PET/CT) study to investigate the clinical predictive value of 68Ga-ICAM-1pep in metastatic cancer patients receiving radiotherapy. A single dose of 2.96 MBq/kg body weight of 68Ga-ICAM-1pep will be injected intravenously. The visual and semiquantitative methods will be used to assess the PET/CT images.
Official title: 68Ga-ICAM-1pep PET/CT Imaging of Tumor Responses to Radiotherapy in Cancer Patients
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2024-09-20
Completion Date
2025-12-31
Last Updated
2024-08-19
Healthy Volunteers
No
Conditions
Interventions
68Ga-ICAM-1pep
68Ga-ICAM-1pep PET/CT: after intravenous injection of 2.96 MBq/kg body weight of quality-controlled 68Ga-ICAM-1pep, a Siemens Biograph PET/CT scan will be applied within 1 h, and the scan range will be from the top of the head to 1/3 of the upper thigh.
Locations (1)
Beijing Cancer Hospital
Beijing, Beijing Municipality, China